Maersk CEO: Limitation of what landside infrastructure can cope with
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Maersk CEO, Vincent Clerc, discusses…
Novo Nordisk CEO addresses investors’ high Wegovy pill expectations
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Novo Nordisk hikes its 2026…
DSV CEO: Freight rates to remain high, disruptions becoming the norm
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jens Lund, CEO of logistics…
Novo Nordisk CEO: ‘80% of Wegovy pill customers’ have never taken a GLP-1 before
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email At the American Diabetes Association’s…
Novo Nordisk CEO: We are a cardiometabolic powerhouse
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email At the American Diabetes Association’s…
Novo Nordisk’s Pipeline Humming, but Shares Remain Stuck in Neutral
Novo Nordisk shares slip 4.35% as pipeline advances—Zenagamtide Phase-3 set, Wegovy combo deal with Veru, and oral Wegovy…
Shipping giant Maersk seeing $500 million in extra costs per month
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Maersk CEO Vincent Clerc discusses…
Denmark faces data center reckoning amid power grid strains
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email In March, Denmark introduced a…
Novo Nordisk beats profit forecasts on bumper Wegovy pill sales
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Strong sales of Novo Nordisk’s…
Open to deals, we need the broadest pipeline in the world
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email CNBC’s Angelica Peebles speaks with…
Novo Nordisk and Hims & Hers to collaborate on weight loss treatment
Danish pharmaceutical group Novo Nordisk and U.S. group Hims & Hers Health have announced a collaboration as part…
Novo Nordisk on GLP-1 generics
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email The patent on semaglutide, found…